BIT Life Sciences, Beijing
2010-05-15
Tentative Program Symposium 1: Research Frontiers on Immune Diseases Session 1-1: The Immunity Diseases Molecular Mechanisms Session 1-2: Immunopathology, Etiology and Pathogenic Role of Complement Session 1-3: Genetics of Immune and Autoimmunity Diseases Session 1-4: Cell and Molecular Biology of Autoimmunity Session 1-5: Tumor Immunology Session 1-6: Innate to Acquired (Adaptive) Immunity and Diseases Session 1-7: Toll-like Receptors and Pattern Recognition Receptors Session 1-8: Immune Signal Transduction and Cross-talk Session 1-9: Immune Regulations- Regulatory T Cells and T Cell Subsets Session 1-10: Dendritic Cells, Macrophages and other Innate Immune Cells Session 1-11: Human Immunology and Immunodeficiencies Session 1-12: Hypersensitivity, Antigen Processing and Presentation Session 1-13: Immunological Inflammations and Vascular Injury Session 1-14: Neuroimmunology, Neuroendocrine Immunology and Psychoneuroimmunology Session 1-15: Natural Killer Cells, Apoptosis & Immunity Session 1-16: Infection and Immunity, Epidemiology of Immune Diseases Session 1-17: Prophylaxis and Intervention Session 1-18: Mucosal Immunology Session 1-19: Immunochemistry & Immunobiology Session 1-20: Immune Tolerance in Autoimmune Disease Symposium 2: Leading Technologies in Immunology Session 2-1: System Biology and Computational Immunology Session 2-2: Hybridoma Technology Session 2-3: Sensitivity and Accuracy in Imaging Immunity Session 2-4: Immunogenomics & Immunoproteomics Session 2-5: Biochips, Microarray Based Technology Session 2-6: New Immune Intervention Technologies Session 2-7: Small RNAs in Development and Immune Diseases Session 2-8: Nucleic Acids in Innate Immunity Session 2-9: The Stem Cells and Implications in Immune Diseases Session 2-10: The SCID Mouse as Model of Immune Diseases Symposium 3: Immune Disease Drug Discovery & Development Session 3-1: Molecular Targets and Biomarkers of Immunotherapeutics Session 3-2: Computer Aided Drug Design & Medicinal Chemistry Session 3-3: Immunopharmacology Session 3-4: Immunosuppression and Immunotherapy Development Session 3-5: Cytokines, Chemokine and Cell Adhesion Molecules and Drug Discovery Session 3-6: Gene and Cell Therapy Session 3-7: Monoclonal Antibody and Antibody Engineering Session 3-8: Innate Immunity and Novel Vaccines Session 3-9: Novel Drug Delivery Systems of Immunotherapeutics Session 3-10: Traditional Medicines for Immune and Inflammatory Diseases Symposium 4: Medical Research and Immune Diseases Session 4-1: Immunity and Emerging Infectious Disease Session 4-2: Hormones and Immune Response Mediated Diseases Session 4-3: Allergy, Asthma & Clinical Immunology Session 4-4: Autoimmunity Mediated Diseases Session 4-5: Lymphocyte Development and Functions in Immune Diseases Session 4-6: Immunosenescence and Clinical Applications Session 4-7: Immunity and Aging Session 4-8: Reproductive Immunology Session 4-9: Neonatal and Maternal Immunization Session 4-10: Translational Immunology Symposium 5: Diagnostics & Immunotherapy of Major Diseases Session 5-1: Biomarkers for Molecular Diagnostics of Immune Diseases Session 5-2: Insulin-Dependent Diabetes Mellitus Session 5-3: Allergy, Asthma and Rheumatoid Arthritis Session 5-4: Inflammatory Bowel Disease and Ocular Inflammation Session 5-5: Vasculitis and Cardiovascular Diseases Session 5-6: Lung Inflammation and Fibrosis Session 5-7: Autoimmune Hepatitis and Chronic Liver Diseases Session 5-8: Multiple Sclerosis, Scleroderma, Myasthenia Gravis, and Neuromuscular Diseases Session 5-9: Systemic Lupus Erythematosus and and Other Connective Tissue Diseases Session 5-10: Psoriasis, Allergic Skin Diseases and ImmunodermatologySession 5-11: Immunotherapy on Reemerging TB and Malaria Session5-12: Immunological Renal Diseases, and Organ Transplant Rejection Session 5-13: Major Cancers- Breast Cancer Session 5-14: Major Cancers-Head, Brain and Neck Cancers Session 5-15: Major Cancers- Cervical and Ovarian Cancer Session 5-16: Major Cancers- Pancreatic , Prostate, and Renal Cancer Session 5-17: Major Cancers- Leukemia, Lymphoma & Melanoma Session 5-18: Major Cancers- Lung Cancer Session 5-19: Major Infectious Diseases- HIV/AIDS and Other Viral Infections Session 5-20: Major Infectious Diseases-Resistant Bacterial Infections Symposium 6: Benchmark Analysis and Case Studies Session 6-1: Anticancer Drugs Session 6-2: Anti-inflammatory Drugs Session 6-3: Anti-allergy and Asthma Drugs Session 6-4: Anti-Infectious Drugs Session 6-5: Anti-Autoimmune Drugs
|